An in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and Fibrinolysis

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Thrombosis Research

Background:

• Thrombotic events pose significant global health risks.
• Tissue plasminogen activator (tPA) is crucial for treating thrombotic disorders but faces limitations in delivery and therapeutic window.
• Magnetic nanoparticles (MNPs) offer a potential solution for targeted tPA delivery.

Purpose of the Study:

• To develop an in vitro model for evaluating thrombolytic therapies enhanced by MNPs.
• To test magnetic drug targeting of MNPs at human-scale distances.
• To assess the efficacy of MNPs in improving tPA delivery and fibrinolysis.

Main Methods:

• Constructed biomimetic vascular channels using blood and endothelial cells.
• Utilized a rotating magnet to propel MNP clusters through channels.
• Analyzed MNP velocities and fibrinolytic effects in static and dynamic conditions.

Main Results:

• MNP clusters were successfully navigated through channels at human-scale distances.
• MNPs demonstrated enhanced tPA delivery, leading to fibrinolysis in 85% of dynamic experiments.
• Observed MNP velocities up to 0.76 cm/sec near the magnet.

Conclusions:

• MNPs show significant potential for improving tPA delivery in treating stroke and other thrombotic conditions.
• The developed model system enables effective comparison of MNP-facilitated drug delivery at a human scale.